Most at-home screening vendors do not run a laboratory. They rent a network of third-party labs and coordinate the handoffs. It works, until it does not. When a plan is evaluating a partner for a program that touches thousands of members and audit-ready quality data, the question of who actually owns the lab turns out to matter a great deal.
SNT Biotech owns and operates its own high-complexity, CLIA-certified and COLA-accredited laboratory. That means we control the analyzers, the validation, the proficiency testing, and the turnaround, rather than depending on whichever outside lab has capacity that week. Board-certified molecular biologists and pathologists oversee testing directly. For HPV, that includes extended genotyping for richer risk stratification.
When engagement, kitting, lab, and reporting live under one roof, your data does not get stitched across systems and vendors. Numerator closure is documented consistently, and there is no finger-pointing when something needs to be traced. One partner owns the outcome end to end.
Owning the lab also unlocks things a coordinator of outside labs typically cannot offer: the ability to bill as a provider or vendor, to bill claims, and to support ECDS measures, plus the flexibility to serve both at-home programs and in-clinic reference testing for the same partner.
An owned lab is not a detail. It is the difference between a vendor that manages relationships and a partner that controls quality. When your quality scores and your members' results depend on it, that control is worth insisting on.
Learn how our owned laboratory powers audit-ready screening.